CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $80,000 | -17.5% | 11,382 | -2.3% | 0.24% | +5.4% |
| Q1 2022 | $97,000 | -17.8% | 11,645 | -33.4% | 0.22% | +18.0% |
| Q4 2021 | $118,000 | -7.1% | 17,493 | -26.9% | 0.19% | +22.7% |
| Q3 2021 | $127,000 | -53.1% | 23,942 | -49.2% | 0.15% | -51.6% |
| Q2 2021 | $271,000 | +12.4% | 47,094 | -9.7% | 0.32% | +20.0% |
| Q1 2021 | $241,000 | +17.0% | 52,181 | +16.8% | 0.26% | -10.8% |
| Q2 2020 | $206,000 | +17.0% | 44,664 | -2.2% | 0.30% | +4.2% |
| Q1 2020 | $176,000 | +1.7% | 45,674 | -0.8% | 0.28% | +85.1% |
| Q4 2019 | $173,000 | – | 46,042 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |